16.2 Renal Filtration, Tubular Transport & Fluid/Acid-Base Balance

16.2 Renal Filtration, Tubular Transport & Fluid/Acid-Base Balance

Independent Study Guide Notice: Independent study guide by OpenExamPrep. This educational resource is developed independently by OpenExamPrep and is not sponsored, endorsed, or affiliated with the National Board of Podiatric Medical Examiners (NBPME) or Meazure Learning.

Glomerular Filtration & Renal Hemodynamics

The kidneys maintain intravascular volume, electrolyte osmolarity, and extracellular fluid acid-base homeostasis while clearing metabolic waste products. The two kidneys receive approximately 20% to 25% of resting cardiac output, representing a Renal Blood Flow (RBF) of roughly 1.2 L/min in a healthy 70-kg adult.

Core Clearance Formulas & Equations

1. Renal Plasma Flow (RPF): $\text{RPF} = \text{RBF} \times (1 - \text{Hematocrit})$ At a normal hematocrit of 0.45, $\text{RPF} = 1200 \times 0.55 \approx 660 \text{ mL/min}$.
2. Renal Clearance ($C_x$): The theoretical volume of plasma completely cleared of a substance $x$ by the kidneys per unit time: $C_x = \frac{U_x \times V}{P_x}$ Where $U_x$ is urine concentration, $V$ is urine flow rate (mL/min), and $P_x$ is plasma concentration.
3. Measurement of Effective RPF via Para-Aminohippuric Acid (PAH):
   • PAH is freely filtered at the glomerulus and avidly secreted by organic anion transporters in the proximal tubule. At low plasma concentrations, PAH undergoes nearly 100% extraction (90% in single pass) from renal arterial blood.
   • Therefore, PAH clearance ($C_{PAH}$) equals Effective Renal Plasma Flow (eRPF ~600--650 mL/min). True $\text{RPF} = \frac{C_{PAH}}{0.90}$.
4. Measurement of Glomerular Filtration Rate (GFR):
   • Inulin Clearance ($C_{inulin}$): Inulin is a fructose polymer that is freely filtered at the glomerulus and is neither reabsorbed, secreted, nor metabolized by the renal tubules. Consequently, inulin clearance is the undisputed gold standard for GFR (~125 mL/min, or ~180 L/day).
   • Creatinine Clearance ($C_{Cr}$): Creatinine is an endogenous breakdown product of skeletal muscle creatine phosphate. Like inulin, it is freely filtered; however, a small fraction (~10% to 20%) is actively secreted by proximal tubule cells. As a result, $C_{Cr}$ slightly overestimates true GFR.
   • Serum Creatinine vs. GFR Relationship: The relationship between serum creatinine and GFR is inverse and non-linear (hyperbolic). GFR must drop by approximately 50% before serum creatinine rises above the normal reference range ($0.7\text{--}1.2 \text{ mg/dL}$), making serum creatinine an insensitive marker for early renal damage.
5. Filtration Fraction (FF): The fraction of renal plasma flow that is filtered across the glomerular filtration barrier into Bowman's space: $\text{FF} = \frac{\text{GFR}}{\text{RPF}} \approx \frac{125 \text{ mL/min}}{625 \text{ mL/min}} = 0.20 \text{ (20\%)}$

                  Glomerular Arteriolar Hemodynamics

     AFFERENT ARTERIOLE                  EFFERENT ARTERIOLE
     [Dilated by Prostaglandins]         [Constricted by Angiotensin II]
              │                                   ▲
              ▼                                   │
     ┌────────────────┐                  ┌────────────────┐
     │    AFFERENT    │══►  GLOMERULAR  ══►    EFFERENT    │
     │   ARTERIOLE    │    CAPILLARIES   │   ARTERIOLE    │
     └────────────────┘   [High P_gc]    └────────────────┘
              ▲                │                  ▲
              │                ▼                  │
     NSAIDs BLOCK      Filtration Barrier   ACE-I / ARBs
     Prostaglandins   (Endothelium, GBM,    BLOCK Ang II
     (Afferent Constriction)  Podocytes)    (Efferent Dilation)
     -> RPF drops             │             -> P_gc drops
     -> GFR drops             ▼             -> GFR drops
     -> FF unchanged      BOWMAN SPACE      -> FF drops
                          (Ultrafiltrate)   -> Renal Protection

The Glomerular Filtration Barrier

The glomerular capillary wall consists of three anatomical layers that collectively establish a size-selective and charge-selective barrier:

1. Fenestrated Capillary Endothelium: Pores measuring 70 to 100 nm prevent cellular elements (erythrocytes, leukocytes, platelets) from entering Bowman's space, but allow unrestricted passage of fluid, electrolytes, and small proteins.
2. Glomerular Basement Membrane (GBM): Composed of a dense meshwork of Type IV collagen (specifically $\alpha_3, \alpha_4, \alpha_5$ chains), laminin, nidogen, and negatively charged heparan sulfate proteoglycans. Provides a physical size sieve (excluding molecules $>4 \text{ nm}$) and a formidable negative charge barrier that repels negatively charged polyanions—chiefly serum albumin (molecular radius ~3.6 nm).
3. Visceral Epithelial Layer (Podocytes): Epithelial cells extending interdigitating foot processes (pedicels) that wrap around glomerular capillaries. Between adjacent pedicels lie filtration slit diaphragms (~25 to 30 nm wide) composed of specialized structural proteins: nephrin, podocin, and CD2AP.

Arteriolar Hemodynamics: NSAIDs vs. Angiotensin II & ACE Inhibitors

Glomerular capillary hydrostatic pressure ($P_{GC}$) and plasma flow ($RPF$) are independently governed by vascular resistance in the afferent and efferent arterioles:

Nephron Segment Transport & Diuretic Pharmacology

                     Segmental Nephron Transport Mechanisms

     PROXIMAL CONVOLUTED TUBULE (PCT)         THICK ASCENDING LIMB (TAL)
     - 65% Na+, K+, Cl-, H2O (Isotonic)       - 25% Na+, K+, 2Cl- via NKCC2
     - 100% Glucose (SGLT2), Amino Acids      - Water IMPERMEABLE ("Diluting")
     - 85% HCO3- via Carbonic Anhydrase       - Lumen-positive potential (+8 mV)
     - Target: ACETAZOLAMIDE (CA IV/II)         drives paracellular Ca2+, Mg2+
     - URAT1: Uric acid (Probenecid target)   - Target: FUROSEMIDE (Loop Diuretic)
     ───────────────────────────────────────  ───────────────────────────────────────
     DISTAL CONVOLUTED TUBULE (DCT)           COLLECTING DUCT (CD)
     - 5-10% Na+, Cl- via NCC cotransporter   - PRINCIPAL CELLS:
     - Water IMPERMEABLE                        ENaC reabsorbs Na+; ROMK secretes K+
     - Active Ca2+ reabsorption via TRPV5       Aldosterone stimulates ENaC / Na+/K+
       (Stimulated by PTH)                      ADH stimulates AQP2 insertion (V2/cAMP)
     - Target: THIAZIDES (HCTZ, Chlorthalidone) - Target: SPIRONOLACTONE, AMILORIDE
       *Thiazides DECREASE urine Ca2+*        - INTERCALATED CELLS (α-type):
                                                H+-ATPase secretes acid, reabsorbs HCO3-

1. Proximal Convoluted Tubule (PCT)

• Primary Engine: Driven by the basolateral $Na^+/K^+$ ATPase, which pumps 3 $Na^+$ out and 2 $K^+$ in, maintaining a low intracellular $Na^+$ concentration ($~15 \text{ mM}$) and a negative intracellular potential ($-70 \text{ mV}$).
• Isotonic Reabsorption: Approximately 65% to 70% of all filtered $Na^+$, $H_2O$, $K^+$, and $Cl^-$ is reabsorbed here isotonically (tubular fluid osmolarity remains ~300 mOsm/kg).
• Glucose and Solute Cotransport: 100% of filtered glucose and amino acids are reabsorbed in early PCT via sodium-dependent secondary active transporters: SGLT2 (apical high-capacity, low-affinity $Na^+$-glucose cotransporter in S1 segment) and SGLT1. The tubular transport maximum ($T_m$) for glucose is approximately $375 \text{ mg/min}$. When plasma glucose exceeds $180\text{--}200 \text{ mg/dL}$ (the renal threshold), SGLT transporters saturate, causing glucosuria and secondary osmotic diuresis.
• Bicarbonate Reabsorption & Carbonic Anhydrase: 85% of filtered $HCO_3^-$ is reclaimed in the PCT:
  1. The apical $Na^+/H^+$ exchanger 3 (NHE3) secretes $H^+$ into the tubular lumen in exchange for luminal $Na^+$.
  2. In the lumen, secreted $H^+$ combines with filtered $HCO_3^-$ to form carbonic acid ($H_2CO_3$).
  3. Apical Carbonic Anhydrase IV (CA IV) rapidly dehydrates $H_2CO_3$ into $CO_2$ and $H_2O$.
  4. $CO_2$ diffuses passively across the apical membrane into the tubule cell.
  5. Inside the cell, Cytoplasmic Carbonic Anhydrase II (CA II) hydrates $CO_2 + H_2O$ back into $H_2CO_3$, which dissociates into $H^+$ and $HCO_3^-$.
  6. Intracellular $H^+$ is recycled back into the lumen via NHE3, while $HCO_3^-$ is extruded across the basolateral membrane into peritubular capillaries via the $Na^+/HCO_3^-$ cotransporter (NBCe1).
  • Acetazolamide: Selectively inhibits both CA IV and CA II. Blocks $HCO_3^-$ reabsorption, inducing brisk bicarbonate diuresis, urinary alkalinization ($pH > 7.5$), and a Normal Anion Gap Hyperchloremic Metabolic Acidosis (used to treat acute mountain sickness and metabolic alkalosis).
• Uric Acid Transport (Podiatric Significance): The early PCT reabsorbs over 90% of filtered urate via the apical URAT1 anion exchanger. Probenecid and sulfinpyrazone competitively inhibit URAT1, blocking urate reabsorption to promote renal uric acid excretion in chronic tophaceous gout.

2. Loop of Henle & Countercurrent Multiplication

• Thin Descending Limb: Highly permeable to water via constitutive Aquaporin-1 (AQP1) channels; virtually impermeable to $NaCl$ and urea. As fluid descends into the hypertonic renal medulla, water exits osmotically, concentrating tubular fluid up to 1200 mOsm/kg at the hairpin bend.
• Thick Ascending Limb (TAL): Completely impermeable to water! Actively reabsorbs ~25% of filtered $Na^+, K^+$, and $2Cl^-$ via the apical electroneutral NKCC2 cotransporter.
• Lumen-Positive Transepithelial Potential: Some reabsorbed $K^+$ leaks back into the tubular lumen through apical ROMK (Renal Outer Medullary Potassium) channels. This retrograde positive charge leakage establishes a lumen-positive transepithelial electrical potential of $+8 \text{ to } +10 \text{ mV}$. This positive luminal voltage repels divalent cations, driving the paracellular reabsorption of Calcium ($Ca^{2+}$) and Magnesium ($Mg^{2+}$) through claudin-16/19 tight junction pores.
• Loop Diuretics (Furosemide, Bumetanide, Torsemide, Ethacrynic Acid):
  • Reversibly inhibit the $Cl^-$ binding site of the NKCC2 cotransporter.
  • Abolish the lumen-positive potential, blocking paracellular $Ca^{2+}$ and $Mg^{2+}$ reabsorption, causing hypocalcemia and hypomagnesemia ("Loops Lose Calcium").
  • Destroy the corticomedullary osmotic gradient, rendering the collecting duct unable to concentrate urine even in the presence of maximal ADH.

3. Distal Convoluted Tubule (DCT)

• Solute Transport: Reabsorbs 5% to 10% of filtered $Na^+$ and $Cl^-$ via the apical electroneutral NCC ($Na^+/Cl^-$) cotransporter; completely impermeable to water ("cortical diluting segment").
• Thiazide Diuretics (Hydrochlorothiazide, Chlorthalidone):
  • Inhibit the NCC cotransporter in the early DCT, causing mild natriuresis.
  • Paradoxical Calcium Retention: By inhibiting $Na^+$ entry, thiazides lower intracellular $[Na^+]$, accelerating basolateral $Na^+/Ca^{2+}$ exchanger (NCX1) activity. This hyperpolarizes the apical membrane, opening apical TRPV5 calcium channels and markedly increasing active $Ca^{2+}$ reabsorption. Consequently, Thiazides cause HYPOCALCIURIA and mild HYPERCALCEMIA ("Thiazides Take Calcium"), making them the drug of choice for recurrent calcium oxalate nephrolithiasis.

4. Collecting Duct: Principal vs. Intercalated Cells

1. Principal Cells (Sodium, Potassium & Water Regulation):
   • ENaC (Epithelial Sodium Channel): Apical channel that passively reabsorbs $Na^+$ down its electrochemical gradient. Basolateral $Na^+/K^+$ ATPase extrudes $Na^+$ and pumps $K^+$ in. Luminal $K^+$ is then secreted down its gradient through apical ROMK and BK channels.
   • Aldosterone Regulation: Aldosterone diffuses into principal cells, binds cytoplasmic Mineralocorticoid Receptors (MR), translocates to the nucleus, and upregulates transcription of ENaC, ROMK, and $Na^+/K^+$ ATPase. Net action: Increases $Na^+$ and water retention, increases $K^+$ secretion and urinary excretion.
   • Potassium-Sparing Diuretics:
     • Aldosterone Antagonists (Spironolactone, Eplerenone): Competitively block MR.
     • ENaC Blockers (Amiloride, Triamterene): Directly plug the ENaC channel.
     • Both classes prevent $Na^+$ entry, abolish the negative luminal potential, and shut down $K^+$ secretion, causing natriuresis with hyperkalemia risk.
   • Antidiuretic Hormone (ADH / Vasopressin / AVP): Secreted by the posterior pituitary in response to hyperosmolarity ($>285 \text{ mOsm/kg}$) or hypovolemia. ADH binds basolateral $V_2$ receptors ($G_s \rightarrow \text{adenylyl cyclase} \rightarrow cAMP \rightarrow PKA$), triggering the exocytic insertion of Aquaporin-2 (AQP2) water channels into the apical membrane. Water is reabsorbed down the medullary osmotic gradient, producing concentrated urine (up to 1200 mOsm/kg).
2. Intercalated Cells (Acid-Base Regulation):
   • $\alpha$-Intercalated Cells (Acid Secretion): Active during systemic acidosis. Possess an apical vacuolar $H^+$-ATPase and $H^+/K^+$-ATPase that actively pump $H^+$ into the lumen against profound chemical gradients (dropping urine pH to 4.5). Intracellular $HCO_3^-$ is returned to the blood via the basolateral Anion Exchanger 1 (AE1 / $Cl^-/HCO_3^-$ exchanger).
   • $\beta$-Intercalated Cells (Bicarbonate Secretion): Active during systemic alkalosis. Possess apical pendrin ($Cl^-/HCO_3^-$ exchanger) to secrete bicarbonate into urine, and basolateral $H^+$-ATPase to return $H^+$ to blood.

Acid-Base Physiology & Systematic Diagnostic Algorithm

Acid-base homeostasis maintains arterial extracellular pH strictly between 7.35 and 7.45 ($[H^+] = 35\text{--}45 \text{ nEq/L}$), regulated by the carbonic acid-bicarbonate buffer system: $CO_2 + H_2O \rightleftharpoons H_2CO_3 \rightleftharpoons H^+ + HCO_3^-$ $\text{pH} = 6.1 + \log_{10} \left( \frac{[HCO_3^-]}{0.03 \times P_a CO_2} \right)$

The Stepwise Clinical Algorithm

1. Evaluate Arterial pH:
   • $\text{pH} < 7.35 \implies$ Acidemia.
   • $\text{pH} > 7.45 \implies$ Alkalemia.
2. Identify Primary Disturbance:
   • If acidemic and $[HCO_3^-] < 22 \text{ mEq/L} \implies$ Metabolic Acidosis.
   • If acidemic and $P_a CO_2 > 45 \text{ mmHg} \implies$ Respiratory Acidosis.
   • If alkalemic and $[HCO_3^-] > 26 \text{ mEq/L} \implies$ Metabolic Alkalosis.
   • If alkalemic and $P_a CO_2 < 35 \text{ mmHg} \implies$ Respiratory Alkalosis.
3. Assess Adequacy of Compensation:
   • The body never overcompensates; compensation moves pH toward, but does not fully reach, 7.40.
4. If Metabolic Acidosis, ALWAYS Calculate the Serum Anion Gap: $\text{Anion Gap} = [Na^+] - ([Cl^-] + [HCO_3^-])$
   • Normal Serum Anion Gap: $8 \text{ to } 12 \text{ mEq/L}$ (reflects unmeasured polyanions, primarily albumin: $\sim 2.5 \text{ mEq/L}$ per $1 \text{ g/dL}$ of albumin).

                  Diagnostic Tree for Metabolic Acidosis

                       METABOLIC ACIDOSIS
                      (pH < 7.35, HCO3- < 22)
                                │
                     Calculate Serum Anion Gap
                     [Na+] - ([Cl-] + [HCO3-])
                                │
            ┌───────────────────┴───────────────────┐
            ▼                                       ▼
   ELEVATED ANION GAP (>12)                NORMAL ANION GAP (8-12)
   [MUDPILES / GOLDMARK]                   [Hyperchloremic Acidosis]
   - Methanol (Formic acid)                - Severe Diarrhea (loss of HCO3-)
   - Uremia (Renal Failure)                - Renal Tubular Acidosis (RTA):
   - Diabetic Ketoacidosis (DKA)             * Type 1: Distal (H+ secretion fail)
   - Propylene glycol                        * Type 2: Proximal (HCO3- wasting)
   - Iron / Isoniazid                        * Type 4: Hypoaldosteronism (High K+)
   - Lactic Acidosis (Shock, Sepsis)       - Acetazolamide (CA inhibition)
   - Ethylene Glycol (Oxalate crystals)    - Normal Saline (0.9% NaCl infusion)
   - Salicylates (Aspirin Toxicity)        ─────────────────────────────────
                                           Calculate Urine Anion Gap (UAG)
                                           [Na+]u + [K+]u - [Cl-]u
                                           - Negative: GI loss (Diarrhea)
                                           - Positive: Renal loss (RTA Type 1)

Metabolic Acidosis Compensation: Winter's Formula

In metabolic acidosis, respiratory compensation occurs immediately via peripheral chemoreceptor stimulation, driving hyperventilation (Kussmaul breathing) to blow off $CO_2$. Expected compensation is calculated using Winter's Formula: $\text{Expected } P_a CO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2$

• If Measured $P_a CO_2 = \text{Expected } P_a CO_2$: Adequate, pure respiratory compensation.
• If Measured $P_a CO_2 > \text{Expected } P_a CO_2$: Inadequate hyperventilation; signifies a concomitant Primary Respiratory Acidosis (e.g., DKA patient with severe respiratory depression or impending fatigue).
• If Measured $P_a CO_2 < \text{Expected } P_a CO_2$: Excessive hyperventilation; signifies a concomitant Primary Respiratory Alkalosis (e.g., salicylate overdose or sepsis).

High Anion Gap vs. Normal Anion Gap Etiologies

1. High Anion Gap Metabolic Acidosis (HAGMA): Unmeasured organic anions accumulate, replacing bicarbonate while chloride remains normal:
   • Methanol: Ingestion of windshield wiper fluid; metabolized by alcohol dehydrogenase to formic acid, causing optic disc hyperemia and "snowfield blindness".
   • Uremia: Advanced renal failure ($GFR < 15\text{--}20 \text{ mL/min}$); failure to excrete organic phosphates, sulfates, and urate.
   • Diabetic Ketoacidosis (DKA): Absolute insulin deficiency triggers uninhibited lipolysis, generating acetoacetate and $\beta$-hydroxybutyrate.
   • Propylene Glycol: Solvent for IV lorazepam/diazepam; metabolized to lactic acid.
   • Iron / Isoniazid.
   • Lactic Acidosis: Tissue hypoperfusion (hypovolemic, cardiogenic, or septic shock) or metformin accumulation halting oxidative phosphorylation.
   • Ethylene Glycol: Ingestion of antifreeze; metabolized to glycolic and oxalic acid, producing acute oliguric acute tubular necrosis, marked hypocalcemia, and pathognomonic envelope-shaped calcium oxalate crystals in urine sediment.
   • Salicylates (Aspirin): Classic Mixed Acid-Base Disorder: direct stimulation of the medullary respiratory center induces immediate Primary Respiratory Alkalosis, while uncoupling of oxidative phosphorylation generates ketoacids and lactic acid, producing a concurrent Primary High Anion Gap Metabolic Acidosis.
2. Normal Anion Gap Metabolic Acidosis (NAGMA / Hyperchloremic): Bicarbonate is lost directly from the GI tract or kidneys. To maintain electroneutrality, the kidneys reabsorb chloride, resulting in hyperchloremia ($[Cl^-] > 108 \text{ mEq/L}$).
   • Diarrhea: Stool fluid is rich in $HCO_3^-$ and $K^+$; massive diarrhea produces NAGMA with hypokalemia.
   • Renal Tubular Acidosis (RTA):
     • Type 1 (Distal) RTA: Inability of $\alpha$-intercalated cells to secrete $H^+$ via apical $H^+$-ATPase. Urine pH is persistently $> 5.5$ despite systemic acidemia; associated with hypokalemia, calcium phosphate nephrolithiasis, and nephrocalcinosis.
     • Type 2 (Proximal) RTA: Inability of PCT to reabsorb $HCO_3^-$ (often part of Fanconi syndrome). Urine pH variable; hypokalemia, osteomalacia, no nephrolithiasis.
     • Type 4 (Hyperkalemic) RTA: Aldosterone deficiency or resistance (diabetic nephropathy, NSAIDs, ACE inhibitors). Impaired distal $Na^+$ reabsorption and $K^+/H^+$ excretion $\implies$ HYPERKALEMIA with urine $pH < 5.5$.

Metabolic Alkalosis: Saline-Responsive vs. Saline-Resistant

Metabolic alkalosis ($pH > 7.45, [HCO_3^-] > 26$) is evaluated clinically by measuring Urine Chloride ($[Cl^-]_u$):

1. Saline-Responsive ($[Cl^-]_u < 20 \text{ mEq/L}$): Characterized by extracellular volume depletion, hypochloremia, and secondary hyperaldosteronism. Etiologies: vomiting / nasogastric suction (loss of gastric $HCl$) or prior diuretic therapy (loop/thiazides). Infusion of isotonic normal saline (0.9% NaCl) restores intravascular volume and chloride, enabling the kidneys to excrete excess bicarbonate, curing the alkalosis.
2. Saline-Resistant ($[Cl^-]_u > 20 \text{ mEq/L}$): Characterized by normovolemia or hypervolemia with autonomous mineralocorticoid excess: Primary Hyperaldosteronism (Conn syndrome), Cushing syndrome, or genetic channelopathies (Bartter, Gitelman, Liddle syndromes). Unresponsive to saline infusion; requires mineralocorticoid receptor antagonism or surgical excision.